Breaking
FDA approves Rusfertide for erythrocytosis in polycythemia veraDOJ Drops Olmstead Defense as Texas v. Kennedy AdvancesNew Study Examines Weight Loss OutcomesNew three-stage framework targets early arthritis detectionLung Cancer Task Force Maps Roadmap to Close Survival GapCAR T Cell Therapy Gets New Guidelines

polycythemia vera

FDA approves Rusfertide for erythrocytosis in polycythemia vera
Gut Health

FDA approves Rusfertide for erythrocytosis in polycythemia vera

FDA approves rusfertide (Mimrylo) for erythrocytosis, sparing polycythemia vera patients from painful phlebotomies. Read the latest medical news.

Persephone Blackwood · August 30, 2026